2023 Tom Isaacs Award honours Dr Natasha Fothergill-Misbah
29 September 2023 Cure Parkinson’s and Van Andel Institute (VAI) are delighted to announce Dr Natasha Fothergill-Misbah, Research Associate at Newcastle University, as the winner of the 2023 Tom Isaacs Award. The award was presented on September 28 in Newcastle, as part of the annual…
Helen Matthews takes the helm as new CEO of Cure Parkinson’s
10 August 2023 We are delighted to announce that Helen Matthews will be taking over as CEO of Cure Parkinson’s later this summer. As our current Deputy CEO and former COO, Helen has been a driving force behind the charity since it was formed over…
Fundraiser of the Year 2022
11 April 2023 We were delighted to announce the winner of our 2022 Fundraiser of the Year award as the remarkable Simon Cooper. Simon was instrumental in nominating Lloyd’s syndicate AEGIS London as lead sponsor of Cure Parkinson’s Coast-to-Coast-to-Cure cycle challenge in 2019, and in…
European Software Industry helps fund research to cure Parkinson’s
Cure Parkinson’s is delighted to announce that it has been chosen as the official charity partner to Boardwave supporting Parkinson’s research.
Cough medicine offers hope of new treatment to slow the progression of Parkinson’s disease
10 January 2023 Following promising results reported at Phase 2 in 2020, a large-scale Phase 3 clinical trial of ambroxol, a drug currently in use to treat respiratory conditions, will start in early 2023. The ASPro-PD trial is a world-first Phase 3 trial aimed at…